secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0001193125-25-170512
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q4 revenue up 10% to $1.35B, EPS $2.58; dividend raised 13% to $0.60
---------------------------------------------------------------------------

- Q4 revenue $1.35B (+10% YoY, +9% CC); GAAP EPS $2.58 (+30%), non-GAAP EPS $2.55 (+23%).
- Gross margin up 230bps to 60.8% GAAP; operating income $454.5M (+19%).
- FY2025 revenue $5.15B (+10%); GAAP EPS $9.51 (+37%).
- Dividend raised 13% to $0.60/share; payable Sept 18, record Aug 14; ex-div Aug 13.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312525170512/0001193125-25-170512-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312525170512/d926247d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-170512

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer